Tag: SYNGENE INTERNATIONAL

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to SYNGENE INTERNATIONAL

Syngene International Q1 net profit up 33% at Rs 77 cr; John Shaw steps down from board

Added to Collection on: 2021-07-21 06:56:15

Tags for this article:

Economy of India
Biocon
Kiran Mazumdar-Shaw
Indian people
Science and technology in India
SYNGENE INTERNATIONAL

Click the tags to see associated articles and topics

View Article Details
Kiran Mazumdar Shaw's Husband John Shaw Retires From Syngene Board, His Work Appreciated

Added to Collection on: 2021-07-21 14:37:30

Tags for this article:

Economy of India
Organic compounds
Kiran Mazumdar-Shaw
Biocon
Drugs
Kiran
Viyella
Remdesivir
SYNGENE INTERNATIONAL

Click the tags to see associated articles and topics

View Article Details
Dyadic Reports Second Quarter 2021 Financial Results and Highlights Recent Company Progress

Added to Collection on: 2021-08-12 20:08:49

Tags for this article:

Medicine
Medical research
Health sciences
Clinical trials
Health
BioNTech
COVID-19 vaccine
Vaccine
Science diplomacy and pandemics
Oxford–AstraZeneca COVID-19 vaccine
Dyadic International Inc.
Sorrento Therapeutics Inc
SYNGENE INTERNATIONAL
BDI Holdings

Click the tags to see associated articles and topics

View Article Details
FABA Academy's workshop on biologics deliberates on innovations

Added to Collection on: 2021-08-14 15:29:35

Tags for this article:

Life Sciences
Articles
Biotechnology
Pharmaceutical industry
Biocon
Biopharmaceutical
Department of Biotechnology
Biosimilar
Downstream processing
Pune
SYNGENE INTERNATIONAL

Click the tags to see associated articles and topics

View Article Details
Syngene International slides after Q2 FY22 PAT tumbles 21% to Rs 67 cr

Added to Collection on: 2021-10-21 09:46:05

Tags for this article:

Biocon
Finance
Earnings before interest, taxes, depreciation, and amortization
Financial markets
Investment
SYNGENE INTERNATIONAL

Click the tags to see associated articles and topics

View Article Details
Syngene posts Rs 920M PAT in Q2

Added to Collection on: 2021-10-21 09:46:14

Tags for this article:

Organic compounds
Chemistry
Chemical compounds
COVID-19 drug development
Nitriles
Remdesivir
SYNGENE INTERNATIONAL

Click the tags to see associated articles and topics

View Article Details